Simon Tremblay

Simon Tremblay

Research Assistant Professor; Director of Transplant Antihumoral Therapies Program

Medical Sciences Building

1459

COM Surgery Transplant - 0519

Medical Sciences Building
231 Albert Sabin Way
Cincinnati, Ohio 45267-0519

Education

Bachelor's Degree, Université de Montréal, Montréal, Canada 2007 (Pharmacy)

Master's Degree, Université de Montréal, Montréal, Canada 2008 (Pharmaceutical Practice)

Doctor of Pharmacy Degree, University of British Columbia, Canada 2013

Solid Organ Transplant Fellowship, University of Cincinnati Medical Center 2015

Doctor of Philosophy Degree in Epidemiology, University of Cincinnati 2018

Research Support

Grant: #UCSF PEARL II sub Feinstein Institute sub UH2AR067688 Investigators:Abu Jawdeh, Bassam; Alloway, Rita; Anand, Manish; Tremblay, Simon; Woodle, Ervin Steve 06-01-2018 -05-31-2019 National Institute of Arthritis, Musculoskeletal and Skin Disease Pathway Exploration and Analysis in Renal Lupus (PEARL) – Phase 2 Role:Collaborator $83,271.00 Awarded Level:Federal

Grant: #R01 AI139141 Investigators:Driscoll, James; Tremblay, Simon; Woodle, Ervin Steve 12-17-2018 -11-30-2023 National Institute of Allergy and Infectious Diseases Targeting Human Plasma Cells To Overcome Humoral Responses in Transplantation Role:Collaborator $173,143.00 Awarded Level:Federal

Grant: #306067 / R21AI142264 Investigators:Alloway, Rita; Tremblay, Simon; Woodle, Ervin Steve 12-15-2018 -11-30-2020 National Institute of Allergy and Infectious Diseases Single cell analysis of transplant rejection Role:Collaborator $29,553.00 Active Level:Federal

Grant: #S-2744 Investigators:Alloway, Rita; Tremblay, Simon 12-01-2019 -11-30-2020 Dialysis Clinic, Inc. BEST Study - Evaluation of serum belatacept concentrations in renal transplant recipients Role:Collaborator $48,317.00 Awarded Level:Private Non-Profit

Grant: #KPMP / U2CDK114886 Investigators:Alloway, Rita; Tremblay, Simon; Woodle, Ervin 09-01-2019 -08-31-2022 National Inst of Diabetes and Digestive and Kidney Disease Kidney Precision Medicines Project Healthy Living Kidney Donor Tissue Repository Role:Collaborator $100,000.00 Awarded Level:Federal

Publications

Peer Reviewed Publications

Abu Jawdeh, Bassam G; Woodle, Ervin Steve; Leino, Abbie D; Brailey, Paul; Tremblay, Simon; Dorst, Tonya; Abdallah, Mouhamad H; Govil, Amit; Byczkowski, Daniel; Misra, Hemant; Abuchowski, Abraham; Alloway, Rita R (2018. )A phase Ib, open-label, single arm study to assess the safety, pharmacokinetics, and impact on humoral sensitization of SANGUINATE infusion in patients with end-stage renal disease.Clinical transplantation, ,32 (1 ),

Alloway, Rita R; Vinks, Alexander A; Fukuda, Tsuyoshi; Mizuno, Tomoyuki; King, Eileen C; Zou, Yuanshu; Jiang, Wenlei; Woodle, E Steve; Tremblay, Simon; Klawitter, Jelena; Klawitter, Jost; Christians, Uwe (2017. )Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial.PLoS medicine, ,14 (11 ),e1002428

Woodle, E Steve; Tremblay, Simon; Driscoll, James J (2017. )IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation.The New England journal of medicine, ,377 (17 ),1692-3

Tremblay, Simon; Alloway, Rita R (2017. )Clinical Evaluation of Modified Release and Immediate Release Tacrolimus Formulations.The AAPS journal, ,19 (5 ),1332-1347

Woodle, E Steve; Tremblay, Simon; Driscoll, James (2017. )Targeting Plasma Cells with Proteasome Inhibitors: Principles from Primates.Journal of the American Society of Nephrology : JASN, ,28 (7 ),1951-1953

Paterno, Flavio; Girnita, Alin; Brailey, Paul; Witte, David; Wang, Jiang; Cuffy, Madison C; Diwan, Tayyab; Tremblay, Simon; Revollo, Jane Y; Alloway, Rita R; Schoech, Michael R; Anwar, Nadim; Shah, Shimul A; Woodle, Steve E (2016. )Successful Simultaneous Liver-Kidney Transplantation in the Presence of Multiple High-Titered Class I and II Antidonor HLA Antibodies.Transplantation direct, ,2 (12 ),e121

Tremblay, Simon; Kaiser, Tiffany E; Alloway, Rita R; Woodle, E Steve; Diwan, Tayyab S (2016. )Absence of the Effect of Pretransplant Body Mass Index on Post Kidney Transplant Outcomes.Progress in transplantation (Aliso Viejo, Calif.), ,26 (2 ),183-90

Tremblay, Simon; Lau, Tim T Y; Ensom, Mary H H Addition of rifampin to vancomycin for methicillin-resistant Staphylococcus aureus infections: what is the evidence?.The Annals of pharmacotherapy, ,47 (7-8 ),1045-54

Verret, Lucie; Couturier, Justine; Rozon, Andréanne; Saudrais-Janecek, Sarah; St-Onge, Amélie; Nguyen, Angela; Basmadjian, Arsène; Tremblay, Simon; Brouillette, Denis; de Denus, Simon (2012. )Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial.Pharmacotherapy, ,32 (10 ),871-9

Lichvar, Alicia; Tremblay, Simon; Naik, Devanshi; Lipscomb, Jessi; King, Eileen; Vinks, Alexander A; Christians, Uwe; Alloway, Rita R (2019. )Evaluation of Clinical and Safety Outcomes Following Uncontrolled Tacrolimus Conversion in Adult Transplant Recipients.Pharmacotherapy, ,

Alloway R.R.; Brailey P.A.; Driscoll J.J.; Girnita A.L.; Hildeman D.A.; Rike-Shields A.; Tremblay S.; Woodle E.S. (02-01-2020. )A prospective, iterative, adaptive trial of carfilzomib-based desensitization.American Journal of Transplantation, ,20 (2 ),411-421

Alloway R.R.; Aronow B.; Brailey P.; Dasgupta N.; Driscoll J.J.; Ebstein F.; Girnita A.; Kim K.B.; Kloetzel P.M.; Lee M.J.; Singh H.; Tremblay S.; Woodle E.S. (02-01-2020. )Proteasomal adaptations underlying carfilzomib-resistance in human bone marrow plasma cells.American Journal of Transplantation, ,20 (2 ),399-410

Borie D.; Brunetta P.; Busque S.; Cascino M.; Desai N.; Formica R.; Green C.; Jamois C.; Jordan S.; Looney C.; Morimoto A.; Rajwanshi R.; Redfield R.; Reed E.; Schindler T.; Schroeder A.; Tran H.; Tremblay S.; Vincenti F.; Vo A.; Woodle E.; Zachary A. (11-01-2019. )Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclona.American Journal of Transplantation, ,19 (11 ),3035-3045

Campara M.; Ensor C.; Hofmeyer B.; Lushin E.; Potter L.; Tremblay S.; Wilson N. (01-01-2019. )Discharge medication procurement and education after kidney transplantation.Clinical Transplantation, ,33 (8 ),

Alloway R.R.; Brailey P.; Bruno K.; Cicerchi J.; Cline A.; Dorst T.; Farnsworth M.; Fernandez D.A.; Girnita A.; Kaufman D.B.; King E.C.; Leone J.; Lipscombe J.; Matas A.; Naciff-Stahl A.; Rohan J.; Sa T.; Schneider K.; Shields A.R.; Stucke A.; Thomas J.; Tremblay S.; West-Thielke P.; Wiseman A.; Woodle E.S. (01-01-2019. )Belatacept-based immunosuppression with simultaneous calcineurin inhibitor avoidance and early corti.American Journal of Transplantation, ,

Alloway R.; Nigro V.; Tremblay S.; Woodle E. (06-01-2017. )Reply to “Fluctuation Does Not Mean Variability: A Pharmacokinetic Point of View”.American Journal of Transplantation, ,17 (6 ),1693

Alloway R.; Nigro V.; Tremblay S.; Weinberg J.; Woodle E. (02-01-2017. )A Steady-State Head-to-Head Pharmacokinetic Comparison of All FK-506 (Tacrolimus) Formulations (ASTC.American Journal of Transplantation, ,17 (2 ),432-442

Basmadjian A.; Brouillette D.; De Denus S.; Justine Couturier; Nguyen A.; Rozon A.; Saudrais-Janecek S.; St-Onge A.; Tremblay S.; Verret L. (04-01-2013. )Erratum: Impact of a pharmacist-led warfarin self-management program on quality of life and anticoag.Pharmacotherapy, ,33 (4 ),464

Contact Information

Academic - Medical Sciences Building
231 Albert Sabin Way
Cincinnati  Ohio, 45267-0519
Phone: 513-558-9967
tremblsn@ucmail.uc.edu